Plasma Fibroblast / Plasma Pen: Evidence, Risks and Availability

Plasma Fibroblast and Plasma Pen: Evidence, Risks and Availability

Plasma fibroblast treatment, sometimes called plasma pen, plasma exeresis or voltaic arc dermabrasion, is an energy-device procedure. A small electrical arc ionises gas near the skin and produces focal thermal injury. The treated points may contract and form a crust while healing. It is a non-surgical procedure, but it deliberately injures the skin and should not be described as non-invasive or risk-free.

This is different from platelet-rich plasma

Plasma fibroblast treatment is different from platelet-rich plasma, or PRP. PRP is prepared from a person’s blood after collection and centrifugation. A plasma pen uses electrical energy and does not inject a blood product. Similar names do not make the procedures interchangeable, and evidence or safety information for one should not be used to promote the other.

What the evidence can and cannot show

Published clinical evidence is limited. One single-centre clinical trial treated 56 women with dermatochalasis and periorbital wrinkles three times at monthly intervals and reported improvement from baseline. The abstract does not describe a separate untreated control group, so it cannot establish how the procedure compares with no treatment or another option. A separate level-IV study of 45 people concerned selected benign facial lesions rather than general facial tightening; transient post-inflammatory pigmentation occurred in three participants. Small studies have also examined crow’s feet. These findings do not establish a predictable result, the best treatment for a concern, or how long any change will last for an individual.

The exact device, energy delivery, settings, treatment area, operator technique, skin characteristics and outcome measure all matter. Claims that the procedure reliably treats wrinkles, scars, pigmentation, loose skin and lesions with minimal downtime go beyond what this limited evidence can support. No cosmetic outcome can be guaranteed.

Recovery and material risks

Expected short-term effects can include pain or stinging, redness, swelling, tenderness and visible crusting or scabbing. Healing time varies. Material risks include burns, blistering, infection, delayed healing, scarring, and post-inflammatory hyperpigmentation or hypopigmentation. Pigment change can be prolonged and may be of particular concern in darker skin tones or after ultraviolet exposure. Picking crusts or using irritating products on unhealed skin may add harm.

Treatment near the eyelids needs particular caution because the skin is thin and the eye is close to the treatment area. Periorbital laxity, hooding and lines can also have different causes and may require an ophthalmic or surgical assessment. Seek urgent medical assessment for eye pain or any change in vision. Severe or worsening pain, spreading redness, pus, fever, marked swelling, blistering or a wound that is not healing also needs prompt clinical advice.

Device and practitioner checks

Before considering any energy-device procedure, ask for the exact device name, manufacturer, UKCA or CE marking where applicable, intended purpose, instructions for use and evidence relevant to the proposed treatment area. A conformity mark does not replace an individual assessment or prove every advertised use. Ask who will perform the procedure, what training and insurance they hold, what settings will be used, how your skin and medical history affect risk, and how complications are recognised and managed.

Tell the assessing clinician about previous procedures, scarring or pigment problems, active skin disease or infection, pregnancy or breastfeeding, allergies, and all medicines and supplements. Do not stop prescribed medicine because of information on this page. A suitable assessment may conclude that no procedure, a different option or specialist referral is appropriate.

Current Dr Sknn availability

Plasma-fibroblast and plasma-pen treatment is not listed as a bookable service in Dr Sknn’s current booking catalogue. This page is patient information and does not represent an offer of that procedure. For services that are currently available, Wilmslow is Dr Sknn’s primary clinic, Didsbury is also active, and Leigh is closed. The exact service, clinic and practitioner combination shown in the current booking app is authoritative because some services are available only at a particular clinic or practitioner level.

All consultations are free. A doctor consultation uses a £50 reservation fee; this is not a consultation charge and is handled under the booking terms. Nurse and qualified-practitioner consultations are free. For services currently listed, use the Dr Sknn pricing board for current public prices. The pricing board is not approved here as a paid-advertising destination.

Sources

Clinical trial of plasma exeresis for periorbital rejuvenation; level-IV study of voltaic arc dermabrasion for selected benign facial lesions; study of voltaic arc dermabrasion for crow’s feet; MHRA information for medical-device users and patients.